4
Changes in Ownership
abrdn Life Sciences Investors Filed Acc 0001510281-25-000315
10% owner sold 23,729 shares at $12.08 ($286,646)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Saba Capital Management, L.P. 10% owner | 2025-05-15 | Sale | −23,729 | $12.08 | $286,646 | 3,028,958 | I: show line 1 in the form |
| Open-market sales · 23,729 sh · avg $12.08 · $286,646 | |||||||
Loading xslF345X05/primary_doc.xml…